Business
Press Release Oct 07 2020
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 07, 2020, titled "Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 07, 2020, titled \"Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg\". View Attachment","length":384,"tagName":"div"}]